However, further investigation using expanded omics approaches will be necessary to elucidate the broader roles and functions of DYRK1B in various cellular-stress pathways relevant to metabolic disorders, as well as its potential as a diagnostic or prognostic biomarker (Tang et al., 2023; Liang et al., 2024). This evidence concerns the gene DYRK1B and Other metabolic disease.